Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

ETR/M3V stock hub

ETR/M3V has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/M3Vis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

42.2M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/M3V

In the news

Latest news · ETR/M3V

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/E13.3

P25 16.4P50 20.9P75 30.4

ROE17.8

P25 -6.7P50 8.5P75 17.2

ROIC19.8

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/M3V market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

EUR

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	112
Employees Change	-4%
Employees Change Percent	-3.45
Enterprise value	EUR 35.7M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Health Information Services
Isin	DE000A0LBFE4
Last refreshed	2026-05-10
Market cap	EUR 42.2M
Price	EUR 23.2
Price currency	EUR
Rev Per Employee	143,404.22x
Sector	Healthcare
Sic	7372
Symbol	etr/M3V
Website	https://www.mevis.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.5%
EV Earnings	11.28x
EV/EBIT	15.39x
EV/EBITDA	14.47x
EV/FCF	9.55x
EV/Sales	2.22x
FCF yield	8.85%
P/B ratio	2.37x
P/E ratio	13.34x
P/S ratio	2.63x
PE Ratio10 Y	10.49x
PE Ratio3 Y	11.01x
PE Ratio5 Y	10.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.44%
EBITDA Margin	15.36%
FCF margin	23.28%
Gross margin	30.37%
Gross Profit	EUR 4.9M
Gross Profit Growth	-17.67%
Gross Profit Growth Q	-35.11%
Gross Profit Growth3 Y	-11.04%
Gross Profit Growth5 Y	-9.72%
Net Income	EUR 3.2M
Net Income Growth	-30.58%
Net Income Growth Q	-59.86%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	-18.05%
Net Income Growth5 Y	-12.57%
Pretax Margin	20.42%
Profit Margin	19.71%
Profit Per Employee	EUR 28,267
Profitable Years	14
ROA	5.54
Roa5y	10.01
ROCE	9.76
ROE	17.76
Roe5y	28.03
ROIC	19.82
Roic5y	43.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.88%
Cagr15y	9.29%
Cagr1y	-8.82%
Cagr3y	-6.51%
Cagr5y	-3.7%
Div CAGR10	0%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth	-30.58
EPS Growth Q	-59.86
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	-18.05
EPS Growth5 Y	-12.57
FCF Growth	31.44%
OCF Growth	23.29%
OCF Growth10 Y	2.99%
Revenue Growth	-5.36x
Revenue Growth Q	-7.01x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.08x
Revenue Growth5 Y	-2.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.61
Assets	EUR 25.9M
Cash	EUR 6.5M
Current Assets	EUR 9M
Current Liabilities	EUR 2.1M
Equity	EUR 17.8M
Interest Coverage	4,020.7
Liabilities	EUR 8.1M
Long Term Assets	EUR 16.9M
Long Term Liabilities	EUR 6M
Net Cash	EUR 6.5M
Net Cash By Market Cap	EUR 15.45
Net Cash Growth	-0.06%
Net Debt EBITDA	EUR -2.64
Net Debt Equity	EUR -0.37
Net Debt FCF	EUR -1.75
Tangible Book Value	EUR 17.8M
Tangible Book Value Per Share	EUR 9.79
WACC	4.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.24
Net Working Capital	EUR 322,591
Quick ratio	4.13
Working Capital	EUR 6.8M
Working Capital Turnover	EUR 2.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	EUR 1.13
Dividend Years	12
Dividend Yield	4.87%
Ex Div Date	2026-03-20
Last Dividend	EUR 0.95
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	20.51%
1Y total return	-8.81%
200-day SMA	24.7
3Y total return	-18.29%
50-day SMA	23.84
50-day SMA vs 200-day SMA	50under200
5Y total return	-17.19%
All Time High	53.89
All Time High Change	-56.95%
All Time High Date	2007-11-16
All Time Low	2.53
All Time Low Change	817%
All Time Low Date	2011-11-18
ATR	0.22
Beta	-0.03
Beta1y	0.19
Beta2y	0.12
Ch YTD	-5.69
High	23.2
High52	26.8
High52 Date	2026-03-10
High52ch	-13.43%
Low	23.2
Low52	22.2
Low52 Date	2026-03-27
Low52ch	4.51%
Ma50ch	-2.7%
Price vs 200-day SMA	-6.08%
RSI	46.91
RSI Monthly	39.13
RSI Weekly	43.61
Sharpe ratio	-0.53x
Sortino ratio	-0.46
Total Return	4.87%
Tr YTD	-2.14
Tr15y	279.07%
Tr1m	2.66%
Tr1w	-0.85%
Tr3m	-1.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 2.3M
Operating Income Growth	-31.13
Operating Income Growth Q	-62.9
Operating Income Growth3 Y	-21.12
Operating Income Growth5 Y	-16.9
Operating margin	14.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	479,388%
Shares Institutions	21.7%
Shares Out	1,820,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 3.7M
Average Volume	32.4x
Bv Per Share	9.79
CAPEX	EUR -140,434
Ch10y	-13.58
Ch15y	171.3
Ch1m	2.66
Ch1w	-0.85
Ch1y	-12.12
Ch3m	-4.92
Ch3y	-27.04
Ch5y	-30.12
Ch6m	-7.2
Change	0%
Change From Open	0
Close	23.2
Days Gap	0
Depreciation Amortization	146,896
Dollar Volume	464
Earnings Date	2026-05-21
EBIT	EUR 2.3M
EBITDA	EUR 2.5M
EPS	EUR 1.74
F Score	5
FCF	EUR 3.7M
FCF EV Yield	10.47x
FCF Per Share	EUR 2.05
Financing CF	-4,560,821
Fiscal Year End	September
Founded	1,997
Graham Number	19.57931
Graham Upside	-15.61
Income Tax	EUR 113,000
Investing CF	945,464
Is Primary Listing	1
Last Earnings Date	2026-01-29
Last Report Date	2025-09-30
Lynch Fair Value	EUR 8.7
Lynch Upside	-62.51
Ma150	24.58
Ma150ch	-5.61%
Ma20	23.08
Ma20ch	0.52%
Net CF	-4,184
Next Earnings Date	2026-05-21
Open	23.2
P FCF Ratio	11.29
P OCF Ratio	10.89
Payment Date	2026-03-24
Ppne	308,772
Price Date	2026-05-08
Price EBITDA	EUR 17.12
Ptbv Ratio	2.37
Relative Volume	0.62x
Revenue	16,061,273x
Tax By Revenue	0.7x
Tax Rate	3.45%
Tr6m	-3.71%
Volume	20
Z Score	4.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/M3V dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.9%

$1.13 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+4.9%

Next ex-dividend date: 2026-03-20

Performance

ETR/M3V stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/M3V?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.7%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

ETR/M3V momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.9

Neutral momentum band

Price vs 200-day MA

-6.1%

50/200-day relationship not available

Beta (5Y)

-0.03

Less volatile than the market

Sharpe ratio

-0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/M3V

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/M3V stock rating?

etr/M3V is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/M3V analysis?

The full report lives at /stocks/etr/M3V/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/M3V?

The latest report frames etr/M3V around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/M3V page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.